Memorial Sloan Kettering Cancer Center shared a post on LinkedIn:
“In 2014, Dr. David Solit, a physician-scientist at Memorial Sloan Kettering Cancer Center (MSK), set out to decode the mutations that drive a rare type of ovarian cancer. Nearly 10 years later, that laboratory work became Ellen’s lifeline.
Facing a hard to treat diagnosis that resisted standard care, Ellen joined a clinical trial led by MSK gynecological oncologist Dr. Rachel Grisham, based on Dr. Solit’s discovery a decade ago.
The results were dramatic. Within four months of taking a drug targeting the mutation, Ellen’s cancer had shrunk by 70%.
Watch more Saved by Science stories on YouTube.”
Other articles featuring Memorial Sloan Kettering Cancer Center on OncoDaily.